Twenty plants that are used in traditional medicine in Iringa, Tanzania, were tested for in vitro cytotoxic activity on human bladder carcinoma (RT-4), colon adenocarcinoma (HT29), and skin carcinoma (A431) cell lines. At 100 pglml Albizia harveyi, Albizia anthelmintica, Dalbergia nitidula, Euphorbia grantii and Rauvolfia caffra reduced cell proliferation to 50% o r more of the three cell lines. Albizia harveyi showed a significant cytotoxic activity on the RT-4 cell line (percentage survival 23%) at 10pgIml. It showed a weak cytotoxic activitv on the HT-29 cell line. Dalbergia nitidula. showed a weak cytotoxic activity with percentage death of the RT-4 and HT-29 cell lines of 39 and 34%, respectively, a t the 10 pghnl level. These results show that 19 (95%) of the plant extracts tested are non-toxic. One plant (5%), Albizia harveyi showed cytotoxic activity on one of the cell lines used, which was in agreement with the accepted detection level of biological activity by chance. Bioassay guided fractionation of the plant extracts to identify active compound(s) is suggested.
INTRODUCTION
Tanzania has a wealth of flora comprising over 10,000 plant species, of which 1 122 are endemic [1, 2] . Many of these plants are used as medicines by the rural populations [3] . It has also been reported that 2 1% of the people who utilize public health services in Dar es Salaam consult a traditional healer before doing so [4] . This finding indicates the popularity of traditional medicines and point to the possibility that some of these plants may indeed be effective, although most of them are yet to be exploited.
One of the ways in which these therapies could be identified and utilized is by conducting disease-related ethnobiomedical surveys. This is an interdisciplinary approach which involves the collaboration of medical doctors, ethnobotanists, indigenous healers and communities [5, 6, 7] . The establishment of such a team permits the physician to interact with the healers in evaluation of :he clinical diagnosis, while at the same time the ethnobotanist can identify the plants being used as medicines [7] . The information collected can then be compared with that in literature to assist in developing a list of priority plants for both phytochemical and pharmacological studies.
In this study, twenty plants used by traditional healers in Iringa region (Tanzania), were evaluated for cytotoxic activity on three human cancer cell-lines.
MATERIALS AND METHODS

Materials
RT-4 (human bladder carcinoma), HT29 (human colon adenocarcinoma) and A43 1 (human skin carcinoma) cell lines were obtained from American Type Culture Collection (Rockville, MD, USA), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) was bought from Sigma (St. Louis, MO, USA), the cell culture media and ingredients and phosphate-buffered saline (PBS) were obtained from Gibco (Gibco BRL, Paisley, Scotland). Microtitre tissue culture plates were bought from Falcon (NJ, USA) and dimethylsulfoxide (DMSO) was obtained from Sigma (Poole, Dorset, England). 
Plant preparation
The plant materials were dried in open air under the sun, ground into powders and then 50 g extracted with 20% aqueous ethanol. The extracts were dried by rotary evaporation and the remaining traces of water weiae removed by freeze-drying. The dry extracts, ranging from 0.5 to I . O g/50 g of starting material were stored in plastic containers at -20 "C, until needed for testing.
Cell culture
Human bladder carcinoma (RT-4), human colon adenocarcinoma (HT29), and human skin carcinoma (A43 1) cells were grown at 37 "C in humidified 5% COz and 95% air atmosphere in Minimum Essential Medium (MEM) with Earle's Salt containing 2 mM L-glutamine, 1% antibiotic/antimycotic solution, 1% nonessential amino acids, 1 % anti-PPLO agent, and 10% fetal calf serum.
Antiproliferative assay
Extracts were first dissolved in DMSO to make stock solutions and then diluted in culture medium to yield an extract solution with a final DMSO concentration of 0.1% vlv. This concentration of DMSO did not affect cell viability. Cells were seeded onto 96-well microtitre tissue culture plates at 5 x lo3 cells per well and incubated for 24 h at 37 "C. The medium was replaced with fresh medium containing different concentrations of extracts (100 pg/ml and 10 pg/ml) or the vehicle. The cells were then incubated at 37 OC for 72 h. Afterwards, the extract-containing medium was removed and cell proliferation was determined. Cell proliferation was determined by using the MTT dye reduction assay. MTT was dissolved in phosphate buffered saline (PBS, 0.01M; pH 7.4) and added to the cells (1 mglml) and the plates were incubated at 37 OC for 4 h. MTT was carefully removed and the resulting formazan crystals were dissolved in DMSO and added onto the wells (100 pllwell). The plates were placed on a shaker for 2 h and then read on a microtitre plate reader (SLT, Salzburg, Austria) at 550 nm. The results are expressed as percentage cell survival as compared to controls. All experiments were performed at least three times. Table 1 shows the names of the twenty plants used, voucher numbers, the parts collected, and the ethnomedical claims for which they were collected. The ethnomedical uses included malaria (40%), epilepsy (40%), diabetes (30%), bilharzia (25%), hypertension (20%), HIV (1 5%), cancer (1 5%), and skin diseases (1 5%). Sixty percent (60%) of the plants had more than one ethnomedical use. Three of the plants collected, Asparagus africanus, Cassia abbreviara and Ziziphus abbyssinica were claimed to be used for the treatment of cancer. Table 2 shows the effect of the plant extracts on cell lines. At 100 pg/ml Albizia harveyi, Albizia anthelmintica, Dalbergia nitidula, Euphorbia grantii and Rauvolfia caffra exhibited up to 50% cytotoxicity on the three cell lines. Only one plant, Albizia harveyi showed a significant cytotoxic activity on the RT-4 cell line (percentage survival 2 3 % ) at 10 pg/ml. The other plant which performed well at 10 pglml is Dalbergia nitidula, with 39 and 34% cytotoxicity on RT-4 and HT-29 cells, respectively.
RESULTS
DISCUSSION
Three of the plants in this study, Asparagus africanus Cassia abbreviata and Ziziphus abbyssinica are used by the local communities in Iringa for the treatment of cancer, but they did not show activity on the three human cancer cell lines. Lannea stuhlmannii, which has similar claims [8] , also gave negative results like two earlier studies, one using brine shrimps [9] and another using HeLa (cervical carcinoma cell line) and A431 cell lines [lo] . Ximenia cafia and Cassia abbreviata have also been retested but, it seems the two plants growing in Iringa were not as active as was expected from the previous study [lo] . Ximenia caffia was inactive on the 3 cell lines at 10 and 100 pglml. also in disagreement with a previous study which gave an LCSO of 0.7 pg/ml on brine shrimps [9] . Gardenia ternfolia [I 1,121 , Mormodica calantha [ 1 31, Rauvolfa cafra [I 41 , Dalbergia nitidula [I 5, 161 , and Euphorbia candelabrum [13] are used for treatment of swellings, external tumors or for dressing wounds. At 10 pglml the only plant which inhibited cell proliferation by more than 50 % was Albizia harveyi, while Euphorbia grantii, Dalbergia nitidula and Rauvolfa cafra showed reasonable inhibition at I00 pg/ml.
CONCLUSION
The results show that 19 (95%) of the plant extracts tested are non toxic. One plant (5%), Albizia harveyi showed cytotoxic activity on one of the cell lines used, in agreement with the accepted detection level of biological activity by chance. Bioassay guided fractionation of the plant extracts to identify active compound(s) is suggested.
